| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 263, Issue 26, 12813-12815, Sep, 1988
SM Hanash, JR Strahler, R Kuick, EH Chu and D Nichols
Department of Pediatrics, University of Michigan Medical School, Ann Arbor 48109.
A novel polypeptide, designated p18, was detected in a variety of hematopoietic cells by two-dimensional polyacrylamide gel electrophoresis. Quantitative analysis of p18 indicated its occurrence in a substantially greater amount in acute leukemia relative to nonleukemic cells. The increased amount of p18 in leukemia could not be explained on the basis of specific lineage, differentiation stage, or cell proliferation and thus appears to be a part of the malignant phenotype of the leukemic cells.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E. Sellin, P. Holmfeldt, S. Stenmark, and M. Gullberg Global Regulation of the Interphase Microtubule System by Abundantly Expressed Op18/Stathmin Mol. Biol. Cell, July 1, 2008; 19(7): 2897 - 2906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Mistry, A. Bank, and G. F. Atweh Synergistic Antiangiogenic Effects of Stathmin Inhibition and Taxol Exposure Mol. Cancer Res., August 1, 2007; 5(8): 773 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Alli, J.-M. Yang, J. M. Ford, and W. N. Hait Reversal of Stathmin-Mediated Resistance to Paclitaxel and Vinblastine in Human Breast Carcinoma Cells Mol. Pharmacol., May 1, 2007; 71(5): 1233 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-T B. Ngo, T. Peng, X.-J. Liang, O. Akeju, S. Pastorino, W. Zhang, Y. Kotliarov, J. C. Zenklusen, H. A. Fine, D. Maric, et al. The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas J Natl Cancer Inst, April 18, 2007; 99(8): 639 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Mistry and G. F. Atweh Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer Mol. Cancer Ther., December 1, 2006; 5(12): 3248 - 3257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Mistry, A. Bank, and G. F. Atweh Targeting stathmin in prostate cancer Mol. Cancer Ther., December 1, 2005; 4(12): 1821 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Unwin, D. W. Sternberg, Y. Lu, A. Pierce, D. G. Gilliland, and A. D. Whetton Global Effects of BCR/ABL and TEL/PDGFR{beta} Expression on the Proteome and Phosphoproteome: IDENTIFICATION OF THE RHO PATHWAY AS A TARGET OF BCR/ABL J. Biol. Chem., February 25, 2005; 280(8): 6316 - 6326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Carter, L. Smith, and M. Ryan Identification and validation of cell surface antigens for antibody targeting in oncology Endocr. Relat. Cancer, December 1, 2004; 11(4): 659 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. JIN, X. O. MAO, B. COTTRELL, B. SCHILLING, L. XIE, R. H. ROW, Y. SUN, A. PEEL, J. CHILDS, G. GENDEH, et al. Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis FASEB J, February 1, 2004; 18(2): 287 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Polager and D. Ginsberg E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress J. Biol. Chem., January 10, 2003; 278(3): 1443 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Liedtke, E. E. Leman, R. E. W. Fyffe, C. S. Raine, and U. K. Schubart Stathmin-Deficient Mice Develop an Age-Dependent Axonopathy of the Central and Peripheral Nervous Systems Am. J. Pathol., February 1, 2002; 160(2): 469 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Iancu, S. Mistry, S Arkin, S Wallenstein, and G. Atweh Effects of stathmin inhibition on the mitotic spindle J. Cell Sci., January 3, 2001; 114(5): 909 - 916. [Abstract] [PDF]
|
|
|
|
 |
|
 S. le Gouvello, V. Manceau, and A. Sobel Serine 16 of Stathmin as a Cytosolic Target for Ca2+/Calmodulin-Dependent Kinase II After CD2 Triggering of Human T Lymphocytes J. Immunol., August 1, 1998; 161(3): 1113 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O Gavet, S Ozon, V Manceau, S Lawler, P Curmi, and A Sobel The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network J. Cell Sci., January 11, 1998; 111(22): 3333 - 3346. [Abstract] [PDF]
|
|
|
|
|
|
S Charrasse, M Schroeder, C Gauthier-Rouviere, F Ango, L Cassimeris, D. Gard, and C Larroque The TOGp protein is a new human microtubule-associated protein homologous to the Xenopus XMAP215 J. Cell Sci., January 5, 1998; 111(10): 1371 - 1383. [Abstract] [PDF]
|
|
|
|
|
|
P. A. Curmi, S. S. L. Andersen, S. Lachkar, O. Gavet, E. Karsenti, M. Knossow, and A. Sobel The Stathmin/Tubulin Interaction in Vitro J. Biol. Chem., October 3, 1997; 272(40): 25029 - 25036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Horwitz, H.-J. Shen, L. He, P. Dittmar, R. Neef, J. Chen, and U. K. Schubart The Microtubule-destabilizing Activity of Metablastin (p19) Is Controlled by Phosphorylation J. Biol. Chem., March 28, 1997; 272(13): 8129 - 8132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. K. Schubart, J. Yu, J. A. Amat, Z.-q. Wang, M. K. Hoffmann, and W. Edelmann Normal Development of Mice Lacking Metablastin (P19), a Phosphoprotein Implicated in Cell Cycle Regulation J. Biol. Chem., June 14, 1996; 271(24): 14062 - 14066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Larsson, H. Melander, U. Marklund, r. Osterman, and M. Gullberg G2/M Transition Requires Multisite Phosphorylation of Oncoprotein 18 by Two Distinct Protein Kinase Systems J. Biol. Chem., June 9, 1995; 270(23): 14175 - 14183. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
